Guidance
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Global Medtech Guidance Tracker: January 2023
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Forty-eight documents have been posted on the tracker since its last update.
Q&A Guidance Document Discusses Laser Product How-Tos
Products like laser pointers, gun sights and lasers used to align machinery fall under a new guidance document from the US FDA, which details the limits on how much radiation these products may emit.
Updated GUDID Data Shows Product Details For 4M Devices
The FDA recently released an updated set of data drawn from devices in the GUDID database, which now includes almost 4 million products.
EU Group Calls For Official Health App Assessments As Google And Apple Act As ‘De Facto Regulators’
The regulation of health and wellness apps in the EU and beyond should involve certification from a third-party organization, while proposed legislation on health data must align with the Medical Device Regulation, warns European Commission group Label2Enable.
News We’re Watching – 13 January
This new Medtech Insight feature compiles news briefs on a range of regulatory and legal happenings. This week: Guidance documents on photobiomodulation devices and COVID-19 submissions; legal settlements for Abbott and Jet Medical; and a new partnership for Pear Therapeutics.
EU Guidance Details When In-House Devices Are Exempt From MDR and IVDR
Another MDCG guidance document is out. It elaborates on Article 5(5) of the new EU medtech regulations, which spares devices made and used in health institutions from needing to conform with most MDR/IVDR requirements.
Global Medtech Guidance Tracker: December 2022
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Forty-nine documents have been posted on the tracker since its last update.
FDA Updates Digital Health Policy Navigator To Add More CDS Info
The FDA has updated its Digital Health Policy Navigator website to include additional examples of how to apply the clinical decision support (CDS) guidance. A graphic from Hyman, Phelps & McNamara shows how the website can be used.
Just Say No: FDA Lays Out Its Definitions Of Delaying Or Denying An Inspection
Longstanding US FDA policy explains what it means for a drug firm to “delay, deny, limit or refuse” an agency inspection. A revised draft guidance document expands the definitions to include device firms as well.
FDA Draft Guidance Clarifies Rules Of Summary Reporting Program
The program allows manufacturers of most lower-risk devices to submit reports of known adverse events via quarterly summaries, rather than individually.
Human Factors Guidance Provides Clarity On Data Necessary In Premarket Submissions
FDA released an updated human factors guidance document on 9 December clarifying the types of human factor data the agency wants to see in pre-market submissions.
Digital Health Regulations: A Year In Review
RQM’s Allison Komiyama and Kevin Go summarized up the year’s changes to digital health regulation and outlined what to expect in the coming year.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.